Results from multiple Phase III trials of Icotrokinra in moderate-to-severe plaque psoriasis and a Phase IIb trial in ...
Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis.
Zacks Investment Research on MSN17h
PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis StudyProtagonist Therapeutics, Inc. PTGX announced positive top-line data from the phase IIb ANTHEM-UC study, which evaluated ...
The market slump continued yesterday as President Donald Trump's "period of transition" fuels stagflation fears. It led to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback